Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vietnam Drug Maker Blames GMP Compliance, Ingredients For Price Rise

This article was originally published in PharmAsia News

Executive Summary

The head of a major biotechnology company in Vietnam blames the recent surge in the prices of vaccines on the cost of imported ingredients and compliance with government regulations. Nguyen Thu Van, director of Vaccine and Bio-Technology Products Co. No. 1, said the cost of being a Good Manufacturing Practice company is part of the reason for the high costs of vaccines. Van said her firm has just submitted its first proposal to the government for a price increase in a year, with some of the vaccines to rise as much as 10 percent. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel